Novel potent and highly selective DDR1 inhibitors from integrated lead finding-Reference-Cited by-同舟云学术

Novel potent and highly selective DDR1 inhibitors from integrated lead finding

Published:2023-05-15 Issue:7 Volume:32 Page:1400-1425
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Kuhn Bernd^ORCID,Ritter Martin,Benz Jörg,Kocer Buelent,Sarie Jérôme C.,Hochstrasser Remo,Rudolph Markus G.,Kadono Shojiro,Matsuura Tetsu,Murata Takeshi,Richter Hans,Prunotto Marco

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s00044-023-03066-2.pdf

Reference42 articles.

1. Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. In: Jeon KW, editor. International review of cell and molecular biology. Academic Press; 2014. p. 39–87. https://doi.org/10.1016/B978-0-12-800180-6.00002-5

2. Moll S, Desmoulière A, Moeller MJ, Pache JC, Badi L, Arcadu F, et al. DDR1 role in fibrosis and its pharmacological targeting. Biochim Biophys Acta Mol Cell Res. 2019;1866:118474 https://doi.org/10.1016/j.bbamcr.2019.04.004

3. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1997;1:13–23. https://doi.org/10.1016/s1097-2765(00)80003-9

4. Yeh YC, Lin HH, Tang MJ. A tale of two collagen receptors, integrin β1 and discoidin domain receptor 1, in epithelial cell differentiation. Am J Physiol-Cell Physiol. 2012;303:C1207–17. https://doi.org/10.1152/ajpcell.00253.2012

5. Borza CM, Pozzi A. Discoidin domain receptors in disease. Matrix Biol. 2014;34:185–92. https://doi.org/10.1016/j.matbio.2013.12.002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDR1-targeted therapies: current limitations and future potential;Drug Discovery Today;2024-05

2. Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies;Pharmaceuticals;2024-03-27